Second-generation Elecsys cerebrospinal fluid immunoassays aid diagnosis of early Alzheimer’s disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Second-generation Elecsys cerebrospinal fluid immunoassays aid diagnosis of early Alzheimer’s disease ; volume:61 ; number:2 ; year:2023 ; pages:234-244 ; extent:11
Clinical chemistry and laboratory medicine ; 61, Heft 2 (2023), 234-244 (gesamt 11)
- Urheber
-
Blennow, Kaj
Stomrud, Erik
Zetterberg, Henrik
Borlinghaus, Niels
Corradini, Veronika
Manuilova, Ekaterina
Müller-Hübner, Laura
Quevenco, Frances-Catherine
Rutz, Sandra
Hansson, Oskar
- DOI
-
10.1515/cclm-2022-0516
- URN
-
urn:nbn:de:101:1-2022121413243924079543
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.08.2025, 07:23 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Blennow, Kaj
- Stomrud, Erik
- Zetterberg, Henrik
- Borlinghaus, Niels
- Corradini, Veronika
- Manuilova, Ekaterina
- Müller-Hübner, Laura
- Quevenco, Frances-Catherine
- Rutz, Sandra
- Hansson, Oskar
Ähnliche Objekte (12)
Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer’s disease
Fluid biomarkers in Alzheimer’s disease – current concepts
Mass Spectrometric Analysis of Cerebrospinal Fluid Ubiquitin in Alzheimer's Disease and Parkinsonian Disorders
A Review of Fluid Biomarkers for Alzheimer’s Disease: Moving from CSF to Blood
Cerebrospinal fluid N-224 tau helps discriminate Alzheimer’s disease from subjective cognitive decline and other dementias
Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
Publisher Correction: Increasing the reproducibility of fluid biomarker studies in neurodegenerative studies
Increasing the reproducibility of fluid biomarker studies in neurodegenerative studies
Peripheral Biomarkers for Alzheimer’s Disease: Update and Progress
Antibodies against phosphorylcholine are not altered in plasma of patients with Alzheimer’s disease
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer’s disease
Fluid biomarkers in Alzheimer’s disease – current concepts
Mass Spectrometric Analysis of Cerebrospinal Fluid Ubiquitin in Alzheimer's Disease and Parkinsonian Disorders
A Review of Fluid Biomarkers for Alzheimer’s Disease: Moving from CSF to Blood
Cerebrospinal fluid N-224 tau helps discriminate Alzheimer’s disease from subjective cognitive decline and other dementias
Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
Publisher Correction: Increasing the reproducibility of fluid biomarker studies in neurodegenerative studies
Increasing the reproducibility of fluid biomarker studies in neurodegenerative studies
Peripheral Biomarkers for Alzheimer’s Disease: Update and Progress
Antibodies against phosphorylcholine are not altered in plasma of patients with Alzheimer’s disease
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer’s disease
Fluid biomarkers in Alzheimer’s disease – current concepts
Mass Spectrometric Analysis of Cerebrospinal Fluid Ubiquitin in Alzheimer's Disease and Parkinsonian Disorders
A Review of Fluid Biomarkers for Alzheimer’s Disease: Moving from CSF to Blood
Cerebrospinal fluid N-224 tau helps discriminate Alzheimer’s disease from subjective cognitive decline and other dementias
Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
Publisher Correction: Increasing the reproducibility of fluid biomarker studies in neurodegenerative studies
Increasing the reproducibility of fluid biomarker studies in neurodegenerative studies
Peripheral Biomarkers for Alzheimer’s Disease: Update and Progress
Antibodies against phosphorylcholine are not altered in plasma of patients with Alzheimer’s disease